Saptalis Pharmaceuticals, LLC

Form 483 issued October 30, 2018 · Hauppauge, New York

Inspection
Oct 15 – Oct 30, 2018
Investigator
Sony Mathews
Observations
3
Pages
2
FEI number
3012152381

In short: On October 30, 2018, FDA issued a Form 483 with 3 observations to Saptalis Pharmaceuticals, LLC in Hauppauge, New York (FEI 3012152381) after an inspection that ran Oct 15 – Oct 30, 2018. The investigator was Sony Mathews. Most observations concern facilities & equipment and materials.

At a glance

Facilities & equipment and materials account for 2 of 3 observations.

Facilities & equipment1
Materials1
Laboratory controls1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in…

  2. 02

    Procedures describing the warehousing of drug…

  3. 03

    The accuracy, sensitivity, and reproducibility of test method…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Saptalis Pharmaceuticals, LLC?

FDA listed 3 observations on this Form 483, mostly about facilities & equipment, materials and laboratory controls. The opening words of each observation are shown on this page.

Who inspected Saptalis Pharmaceuticals, LLC?

Sony Mathews is named on this Form 483, for the inspection of Oct 15 – Oct 30, 2018. Each investigator has a profile showing what they cite most.

When was Saptalis Pharmaceuticals, LLC inspected by FDA?

The inspection ran Oct 15 – Oct 30, 2018, and the Form 483 is dated October 30, 2018.

How do I get the full Form 483 for Saptalis Pharmaceuticals, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free